Lucintel's latest market report analyzed that digital pathology provides attractive opportunities in the pharmaceutical & biotechnology companies, hospitals and reference laboratories, and academic & research institutes. The digital pathology market is expected to reach $1,630.8million by 2028 with a CAGR of 10.3%. In this market, scanners is the largest segment by product, whereas pharmaceutical &bioend use companies is largest by end use.

Download Brochure of this report by clicking on https://www.lucintel.com/digital-pathology-market.aspx

Based on product, the digital pathology market is segmented into scanners, software, and storage systems. The scanners segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, because it helps in converting the images into digital form and also aids in viewing, analysing, managing, sharing, and storing them easily and efficiently.

Browse in-depth TOC on “Digital Pathology Market”

100 – Figures/Tables

150 – Pages

The Digital Pathology Market is marked by the presence of several big and small players. Some of the prominent players offering digital pathology include Leica Biosystems, Koninklijke Philips N.V., Hamamatsu Photonics, F. Hoffmann-La Roche, 3DHISTECH, Apollo Enterprise Imaging, XIFIN, Visiopharm A/S, Aiforia Technologies Oy, Akoya Biosciences, and Corista.

Request Sample Report:

https://www.lucintel.com/digital-pathology-market.aspx

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.